Genet Zemede

Genet Zemede has an extensive work experience in the pharmaceutical industry. Genet started their career in 1999 as a Research Assistant Intern at the Molecular Medicine Research Institute (MMRI). In 2000, they moved to Affymax.Inc as a Research Assistant to Research Associate, Medicinal Chemistry, where they synthesized peptides using solid phase peptide synthesis (SPPS) and solution phase peptide and small molecules synthesis for discovery and development projects. In 2008, they joined Affymax Inc. as a Staff Scientist I, API Manufacturing and Process Development, where they were responsible for developing and optimizing the commercial Omontys™ (Pegnesatide) API manufacturing process. In 2013, they joined Protagonist Therapeutics as a Senior Scientist to Associate Director, Analytical Chemistry/QC, where they managed multiple CMOs and ensured compliance with relevant ICH guidelines, cGMP and FDA regulations. Genet also managed drug substance and drug product ICH stability programs and shelf-life projections, authored and reviewed CMC analytical sections in IND and IMPD drug substance and drug product, and managed analytical documentation into Quality Management System. In 2022, they joined Carmot Therapeutics, Inc. as an Associate Director, Analytical Development.

Genet Zemede received their Master of Science in Biochemistry from San Jose State University in 2006. Genet obtained their Bachelor of Science in Organic Chemistry from the same university in 2000. Prior to that, they earned an Associate of Arts and Sciences in Chemistry from De Anza College. Genet Zemede's education began at Wilcox High School.